The syntheses and antitumor activity of tomaymycin analogs are described. Structural modification of such parts of tomaymycin as the ethylidenepyrrole ring, aminal bond, and substituents of the benzene ring are discussed.
Tomaymycin' is an antitumor antibiotic possessing the pyrrolo [1, 4] benzodiazepine skeleton, which is bound to DNA through a covalent aminal linkage between the 2-amino group of guanine and C-11 of tomaymycin=). Hydrogen bonding between the 8-hydroxyl group of tomaymycin and a phosphorus group of DNA is also an important binding force'). As shown in Table 1 , tomaymycin exhibits marked antitumor activity which fascinated us as a synthetic target. In a previous paper, we reported the total syntheses') of E-(1E) and Z-tomaymycin (1Z) whose structure') was determined on the basis of their 1H NMR and 11C NMR spectra. The synthetic Z-tomaymycin (1Z) exhibited the same antimicrobial activity') as that of naturally occurring E-tomaymycin (1E). We became interested in modification of the active sites of tomaymycin in order to seek more efficient antitumor agents. In this paper, we describe the syntheses of tomaymycin analogs and their antitumor activity.
Chemistry

Modification in the Ethylidenepyrrole Ring of Tomaymycin
Modification in the ethylidenepyrrole ring of tomaymycin was accomplished by the general synthetic route shown in Scheme 1. Condensation of 5-methoxy-2-nitro-4-(4-nitrobenzyloxy)benzoyl chloride (2a) or 4-benzyloxy-5-methoxy-2-nitrobenzoyl chloride (2b) with the modified pyrrole derivatives (3 or 3') according to the SCHOTTEN-BAUMAN method gave the corresponding amides (4 or 4') in good yields. Diphenylmethyl esters (4) were treated with trifluoroacetic acid (TFA) in anisole to give the corresponding acids (4) in good yields. Reduction of the modified pyrrole-2-carboxylic acids (4) with N,N'carbonyldiimidazole and LiAIH, in tetrahydrofuran (THF) by the method of STAAB et al. ' gave the corresponding aldehydes (5) in moderate yields. Catalytic hydrogenation of 5 with 5 % Pd-BaSO, was E-Tomaymycin Z-Tomaymycin THE JOURNAL OF ANTIBIOTICS DEC. 1983 carried out in THE or ethyl acetate (EtOAc) to give the corresponding [1, 4] benzodiazepine derivatives (6) . The similar catalytic hydrogenation of 5 in methanol (MeOH) gave the corresponding methanol adducts of [1, 4] benzodiazepine derivatives (7) .
According to the synthetic route shown in Scheme 2, commercially available L-proline (3a), D,L-2piperidinecarboxylic acid (3b), L-thioproline (3c), and L-hydroxyproline (3d)" were converted to the corresponding [1, 4] benzodiazepine derivatives (6a-d) respectively.
According to the synthetic route shown in Scheme 3, N-t-butoxycarbonyl-4-oxo-L-proline diphenylmethyl ester (8) '' was reacted with methoxyamine to give (E,Z)-N-t-butoxycarbonyl-4-methoxyimino-Lproline diphenylmethyl ester (3"e) in 53 % yield. The WITTIG reaction of 8 with cyanomethylenetri-phenylphosphoranee> gave (E,Z)-N-t-butoxycarbonyl-4-cyanomethylene-L-proline diphenylmethyl ester (3"f) in 89 % yield. The t-butoxycarbonyl group of 3"e and 3"f was removed by treatment with MeOH saturated with hydrogen chloride gas to give 3'e in 65 io yield and 3'f in 62 % yield respectively. 3'e and 3'f were converted to the corresponding [1, 4] by a similar synthetic procedure to that shown in Scheme 1.
According to the synthetic route shown in Scheme 4, N-(4-benzyloxy-5-methoxy-2-nitrobenzoyl)-4-oxo-L-proline (4g) was prepared by oxidation of 4d with JONES reagent7> in 53 % yield. Esterification of 4d with palmitic anhydride gave 4h in 86% yield. 4g and 4h were converted to the corresponding [1, 4] benzodiazepine derivatives (6g) and (7h) respectively by a similar synthetic procedure as shown in Scheme 1. Similarly 7d was prepared from 4d. Antitumor Activity of Tomaymycin Analogs
Antitumor activity of tomaymycin analogs on P388 leukemia was evaluated either by the method of ILS effect or log cell killing. The ILS effect of tomaymycin analogs on P388 leukemia in BDFI mice is shown in Table 2 . A number of tomaymycin analogs modified in the ethylidenepyrrole ring or the benzene ring of tomaymycin led to decrease of potency in antitumor activity. Three analogs, 6a, 6d, and 7d
were active against P388 leukemia. Especially, 6a has effective antitumor activity in a wide range (12.5-150 mg/kg/day). Other analogs, 7a, 6b, 6c, 6f, 6g, and 19 were inactive against P388 leukemia on an intermittent dosage schedule. Melting points were taken with an Arther H. Thomas melting point apparatus and are uncorrected. IR spectra were measured on a Hitachi 260-10 spectrophotometer.
NMR spectra were measured at 100 MHz on a Jeol-MH 100 NMR spectrometer and at 60 MHz on a JNM-PMK 60 NMR spectrometer using Me;Si as an internal standard. 'vlass spectra were measured on a Hitachi M-80 and Jeol JNIS-D 300 mass spectrometer.
Diphenylmethyl Ester (3"e) A solution of 8 (15.0 g), methoxyamine hydrochloride (7.76 g), and triethylamine (50 ml) in ethanol (100 ml) was stirred for 6 hours at 50'C and evaporated in vacuo. To the residue were added EtOAc and H-.O. The organic layer was separated, dried over MgSO{, filtered, and evaporated in vacuo. The residue was chromatographed on silica gel. After elution with n-hexane, subsequently with benzene, and then with diisopropyl ether (IPE), the IPE fraction was evaporated in racuo. The residue was recrystallized from IPE to give 3"e (8. 
N-(4-Benzyloxy-5-methoxy-2-nitrobenzoyl)-4-palmytoyloxy-L-proline (4h)
A solution of 4d (4.16 g) and palmitic anhydride (5.94 g) in pyridine (300 ml) was stirred at 80°C for 15 hours and evaporated in vacuo. To the residue were added EtOAc and H,O, the organic layer was separated, dried over MgSO4, filtered, and evaporated in vacuo. The residue was chromatographed on silica gel. The eluate with chloroform was evaporated in vacuo. The residue was triturated with a mixture of n-hexane and IPE (1: 1) to give 4h (5.60 g, 86%): NMR (CDCI3) 6 0.9 (3H, t, J=3 Hz), 1.3 (11 R, 11aS)(E,Z)-7, 11-Dimethoxy-1, 2, 3, 10, 11, 11 a-hexahydro-8-hydroxy-2-methoxyimino-5-oxo-5H-pyrrolo[2,1-c] [1, 4] 
benzodiazepine (7e)
A solution of 5e in MeOH was hydrogenated as described above to give 7e in 46% yield: IR (Nujol) 1620, 1520 cm-1; NMR (DMSO-d,) 8 (2R,11R,11aS)-7,11-Dimethoxy-1, 2, 3,10,11, l la-hexahydro-8-hydroxy-5-oxo-2-palmytoyloxy-5Hpyrrolo[2,1-c] [1, 4] 
benzodiazepine (7h)
A solution of 5h in MeOH was hydrogenated as described above to give 7h in 18 % yield after column chromatography on silica gel eluted with EtOAc: mp 68 -70°C; IR (Nujol) 1710, 1600 cm-1; NMR (DMSO-de, 100 MHz) 8 0.84 (3H, t, J=3 Hz), 1.24 (26H, br.s), 2.02.4 (4H, m), 3.0~ 3.8 (2H, m), 3.64 (3H, s), 3.9 (3H, s), 4.9-' 5.3 (2H, m), 6.52 (1H, s), 6.84 (1H, s), 7.52 (IH, br.s).
(I1 R, 11aS)(E)-2-Ethylidene-ll-ethylthio-1, 2, 3, 10, 11, 1 la-hexahydro-8-hydroxy-7-methoxy-5-oxo-5H-pyrrolo[2,1-c] [1, 4] 
benzodiazepine (10a)
To a solution of 9 (0.27 g) in methylene chloride (CH,C12) (5 ml) was added ethyl mercaptan (1.5 ml). The solution was kept at room temperature for 6 days and evaporated in vacuo. To the residue were added water and CH,Cl,. The organic layer was separated, dried over MgSO4, filtered, and evaporated in vacuo to give 10a (0.2 g, 60 %) as yellow crystals from methanol: mp 70-' 74°C (dec.); IR (Nujol) 3560, 3350, 1620, 1590 cm-1.
(11 R,1 laS)(E)-l I -Benzylthio-2-ethylidene-1,2,3, 10,11, 11 a-hexahydro-8-hydroxy-7-methoxy-5-oxo-5H-pyrrolo[2,1-c] [1, 4] 
benzodiazepine (10b)
To a solution of 9 (0.54 g) in CH,C12 (5 ml) was added benzyl mercaptan (0.26 g). The solution was kept at room temperature for 4 days and evaporated in vacuo. The residue was submitted to thinlayer chromatography on silica gel to give 10b (0. (11 R,1 l aS)(E)-11-Diethylamino-2-ethylidene -1,2,3,10,11,1 1 a-hexahydro -8 -hydroxy-7-methoxy-5oxo-5H-pyrrolo[2,1-c] [1, 4] 
benzodiazepine (11)
To a solution of 9 (0.54g) in CH2C12 (5 ml) was added 40% aqueous diethylamine (1.2g). The mixture was stirred at room temperature for 5 hours and kept for 4 days. The organic layer was separated, washed with water, dried over MgSO4, filtered, and evaporated in vacuo to give 11 (0.3 g, 43 %) as brown powder: mp 65-' 68°C (dec.); IR (Nujol) 3650, 3500, 1610 cm 1.
6-Benzyloxy-3-methoxy-2-nitrobenzoic Acid (15)
To a mixture of 6-hydroxy-3-methoxy-2-nitrobenzoic acid (14) (2.88 g), NaOH (1.08 g) and H,O (10.8 ml) was added a solution of benzyl bromide (2.78 g) in acetone (5.4 ml). The mixture was stirred at 65°C for 3.5 hours and then poured into H,O. The aqueous layer was separated, washed with ether, adjusted to pH 3 with 15 % hydrochloric acid, and extracted with EtOAc. The extract was washed with brine, dried over MgSO4, and evaporated in vacuo to give 15 (3.70 g, 90.5 %): mp 171 ~ 173°C; IR (Nujol) 1715, 1690, 1370, 1270 cm-1; NMR (DMSO-de) 5 3.85 (3H, s), 5.19 (2H, s), 7.25 -' 7.55 (7H, m).
6-Benzyloxy-3-methoxy-2-nitrobenzoyl Chloride (16)
To a solution of thionyl chloride (1.45 g) in dry benzene (35 ml) was added 15 (1.89 g) and the mixture was refluxed for one hour. The solvent was then removed in vacuo and the residue was triturated with n-hexane and filtrated to give 16 (1.78 g, 89 %): mp 142~ 144°C; IR (Nujol) 1775,1275 cm' 1; NMR (DMSO-de) 3 3.87 (3H,s), 5.21 (2H, s), 7.44 (7H, m).
N-(6-Benzyloxy-3-methoxy-2-nitrobenzoyl)-L-proline (17) A solution of L-proline (3a) (0.76 g) in H2O (15 ml) and THE (7 ml) was adjusted to pH 9 with triethylamine. To the solution was added dropwise a solution of 16 (1.77 g) in THE (20 ml) at 13°C keeping pH between 8.5 -' 9.0 by adding triethylamine. The reaction mixture was stirred for 40 minutes at the same temperature and THE was removed in vacuo. The remained aqueous solution was adjusted to pH 1.0 with conc.HCI to give yellow precipitates of 17 (2.11 g, 96%): IR (Nujol) 1730, 1635, 1450 cm-1; NMR (DMSO-de) 8 and the solution was stirred at 40"C for 2 hours. The solution was cooled down to -20'C and LiAlH, (99 mg) was added, and stirred at the same temperature for 30 minutes. H2O (5 ml) was added and the mixture was filtered. The filtrate was adjusted to pH 8.5. The solution was extracted with EtOAc, washed with brine, dried over MgSO" and evaporated to give 18 (620 mg, 92 %) : IR (Nujol) 1730, 1630 cm-1; NMR (DMSO-d,) 3 
